Tla Targeted Immunotherapies AB
Records under this name other than the patents Tla Targeted Immunotherapies AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 3 of 3 · Back to Tla Targeted Immunotherapies AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,852,581 | Treatment of Inflammatory Bowel Disease Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 9,726,666 | Diagnosing and treating inflammatory diseases Lapsed on the fee record Ended Aug 8, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 8, 2025 | USPTO record |
| US 8,449,489 | Method and means for treating inflammatory bowel disease Lapsed on the fee record Ended May 28, 2025 · USPTO record | Lapsed on the fee record | Ended May 28, 2025 | USPTO record |